These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 19098288)

  • 1. Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53.
    Dayal S; Sparks A; Jacob J; Allende-Vega N; Lane DP; Saville MK
    J Biol Chem; 2009 Feb; 284(8):5030-41. PubMed ID: 19098288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
    Sparks A; Dayal S; Das J; Robertson P; Menendez S; Saville MK
    Oncogene; 2014 Sep; 33(38):4685-96. PubMed ID: 24121268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics in the p53-Mdm2 ubiquitination pathway.
    Brooks CL; Gu W
    Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
    Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
    Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2.
    Stevenson LF; Sparks A; Allende-Vega N; Xirodimas DP; Lane DP; Saville MK
    EMBO J; 2007 Feb; 26(4):976-86. PubMed ID: 17290220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Method for the Purification of Endogenous Unanchored Polyubiquitin Chains.
    Scott D; Strachan J; Krishna VG; Shaw B; Tooth DJ; Searle MS; Oldham NJ; Layfield R
    Methods Mol Biol; 2016; 1449():203-13. PubMed ID: 27613037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin receptors play redundant roles in the proteasomal degradation of the p53 repressor MDM2.
    Sparks A; Kelly CJ; Saville MK
    FEBS Lett; 2022 Nov; 596(21):2746-2767. PubMed ID: 35735670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin- and MDM2 E3 ligase-independent proteasomal turnover of nucleostemin in response to GTP depletion.
    Lo D; Dai MS; Sun XX; Zeng SX; Lu H
    J Biol Chem; 2012 Mar; 287(13):10013-10020. PubMed ID: 22318725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
    Xu C; Fan CD; Wang X
    Oncogene; 2015 Jan; 34(3):281-9. PubMed ID: 24413081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of polyubiquitin isoforms by the multiple ubiquitin binding modules of isopeptidase T.
    Reyes-Turcu FE; Shanks JR; Komander D; Wilkinson KD
    J Biol Chem; 2008 Jul; 283(28):19581-92. PubMed ID: 18482987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 Ubiquitination and proteasomal degradation.
    Love IM; Shi D; Grossman SR
    Methods Mol Biol; 2013; 962():63-73. PubMed ID: 23150437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway.
    Potu H; Peterson LF; Pal A; Verhaegen M; Cao J; Talpaz M; Donato NJ
    Oncotarget; 2014 Jul; 5(14):5559-69. PubMed ID: 24980819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway.
    Brignone C; Bradley KE; Kisselev AF; Grossman SR
    Oncogene; 2004 May; 23(23):4121-9. PubMed ID: 15064742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smurf1 represses TNF-α production through ubiquitination and destabilization of USP5.
    Qian G; Ren Y; Zuo Y; Yuan Y; Zhao P; Wang X; Cheng Q; Liu J; Zhang L; Guo T; Liu C; Zheng H
    Biochem Biophys Res Commun; 2016 Jun; 474(3):491-496. PubMed ID: 27133717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis.
    Fraser JA; Worrall EG; Lin Y; Landre V; Pettersson S; Blackburn E; Walkinshaw M; Muller P; Vojtesek B; Ball K; Hupp TR
    J Mol Biol; 2015 Apr; 427(8):1728-47. PubMed ID: 25543083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auto-ubiquitination of Mdm2 enhances its substrate ubiquitin ligase activity.
    Ranaweera RS; Yang X
    J Biol Chem; 2013 Jun; 288(26):18939-46. PubMed ID: 23671280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The crosstalk between ubiquitin-conjugating enzyme E2Q1 and p53 in colorectal cancer: An in vitro analysis.
    Rasouli M; Khakshournia S; Vakili O; Dastghaib S; Seghatoleslam A; Shafiee SM
    Med Oncol; 2023 Jun; 40(7):199. PubMed ID: 37294480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.
    Yang L; Song T; Cheng Q; Chen L; Chen J
    Mol Cell Biol; 2019 Feb; 39(4):. PubMed ID: 30455251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
    Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
    Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation.
    Nishida T; Yamada Y
    Biochem Biophys Res Commun; 2011 Mar; 406(2):285-91. PubMed ID: 21316347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.